Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1992 Jan;51(1):97–100. doi: 10.1136/ard.51.1.97

Does reduced erythrocyte C3b receptor (CR1) activity contribute to the pathogenesis of yersinia triggered reactive arthritis?

R Lahesmaa 1, E Eerola 1, A Toivanen 1
PMCID: PMC1004628  PMID: 1531747

Abstract

Erythrocyte C3b receptor (CR1) activity was measured in 27 patients with yersinia triggered reactive arthritis and in 151 control subjects, including 36 patients with uncomplicated yersiniosis and 115 healthy subjects. CR1 was measured by the immune adherence haemagglutination method. Patients with yersinia triggered reactive arthritis had reduced levels of CR1 compared with the controls. This difference was mainly due to the finding that five out of six HLA B27 negative patients with arthritis had decreased CR1 activity. Such a quantitative difference may contribute to the pathogenesis of reactive arthritis by affecting the clearance of immune complexes.

Full text

PDF
97

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cohen J. H., Caudwell V., Levi-Strauss M., Bourgeois P., Kazatchkine M. D. Genetic analysis of CR1 expression on erythrocytes of patients with systemic lupus erythematosus. Arthritis Rheum. 1989 Apr;32(4):393–397. doi: 10.1002/anr.1780320407. [DOI] [PubMed] [Google Scholar]
  2. Fearon D. T. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J Exp Med. 1980 Jul 1;152(1):20–30. doi: 10.1084/jem.152.1.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Granfors K., Jalkanen S., von Essen R., Lahesmaa-Rantala R., Isomäki O., Pekkola-Heino K., Merilahti-Palo R., Saario R., Isomäki H., Toivanen A. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med. 1989 Jan 26;320(4):216–221. doi: 10.1056/NEJM198901263200404. [DOI] [PubMed] [Google Scholar]
  4. Granfors K., Viljanen M., Tiilikainen A., Toivanen A. Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis. J Infect Dis. 1980 Apr;141(4):424–429. doi: 10.1093/infdis/141.4.424. [DOI] [PubMed] [Google Scholar]
  5. Iida K., Mornaghi R., Nussenzweig V. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J Exp Med. 1982 May 1;155(5):1427–1438. doi: 10.1084/jem.155.5.1427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kekomäki R., Granfors K., Leino R., Penttinen K., Lindström P. L., Wager O. Clinical correlates of circulating immune complexes in patients with recent yersiniosis. J Infect Dis. 1983 Aug;148(2):223–229. doi: 10.1093/infdis/148.2.223. [DOI] [PubMed] [Google Scholar]
  7. Lahesmaa-Rantala R., Granfors K., Isomäki H., Toivanen A. Yersinia specific immune complexes in the synovial fluid of patients with yersinia triggered reactive arthritis. Ann Rheum Dis. 1987 Jul;46(7):510–514. doi: 10.1136/ard.46.7.510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lahesmaa-Rantala R., Granfors K., Kekomäki R., Toivanen A. Circulating yersinia specific immune complexes after acute yersiniosis: a follow up study of patients with and without reactive arthritis. Ann Rheum Dis. 1987 Feb;46(2):121–126. doi: 10.1136/ard.46.2.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Miyakawa Y., Yamada A., Kosaka K., Tsuda F., Kosugi E., Mayumi M. Defective immune-adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus. Lancet. 1981 Sep 5;2(8245):493–497. doi: 10.1016/s0140-6736(81)90882-5. [DOI] [PubMed] [Google Scholar]
  10. Moldenhauer F., David J., Fielder A. H., Lachmann P. J., Walport M. J. Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus. Arthritis Rheum. 1987 Sep;30(9):961–966. doi: 10.1002/art.1780300901. [DOI] [PubMed] [Google Scholar]
  11. Mäkelä A. L., Eerola E., Lehtonen O. P., Ruuska P., Lantto R. Erythrocyte C3b receptors in juvenile rheumatoid arthritis. N Engl J Med. 1983 Sep 15;309(11):673–673. doi: 10.1056/NEJM198309153091123. [DOI] [PubMed] [Google Scholar]
  12. Thomsen B. S., Jacobsen S. E., Nielsen H., Jakobsen B. K., Sørensen H. Normal distribution of complement C3b receptor (CR1) numbers on erythrocytes in blood donors: low levels are associated with HLA-B27. Complement. 1986;3(2):79–87. doi: 10.1159/000467883. [DOI] [PubMed] [Google Scholar]
  13. Thomsen B. S., Oxholm P., Manthorpe R., Nielsen H. Complement C3b receptors on erythrocytes, circulating immune complexes, and complement C3 split products in patients with primary Sjögren's syndrome. Arthritis Rheum. 1986 Jul;29(7):857–862. doi: 10.1002/art.1780290707. [DOI] [PubMed] [Google Scholar]
  14. Toivanen A., Lahesmaa-Rantala R., Vuento R., Granfors K. Association of persisting IgA response with yersinia triggered reactive arthritis: a study on 104 patients. Ann Rheum Dis. 1987 Dec;46(12):898–901. doi: 10.1136/ard.46.12.898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Walport M. J., Lachmann P. J. Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases. Arthritis Rheum. 1988 Feb;31(2):153–158. doi: 10.1002/art.1780310201. [DOI] [PubMed] [Google Scholar]
  16. Wilson J. G., Murphy E. E., Wong W. W., Klickstein L. B., Weis J. H., Fearon D. T. Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J Exp Med. 1986 Jul 1;164(1):50–59. doi: 10.1084/jem.164.1.50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wilson J. G., Wong W. W., Schur P. H., Fearon D. T. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus. N Engl J Med. 1982 Oct 14;307(16):981–986. doi: 10.1056/NEJM198210143071604. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES